Biological Aging Speed: What a 0.57x Clock Result Really Means

Biological aging speed asks a different question from classic biological age: not only "how old is my body biologically?", but "how fast am I aging right now?". That is why numbers such as 0.57x, 0.72x or 1.10x have become social-media fuel. They sound simple: if 1.00 is average pace, 0.57 looks like aging at almost half speed. The simple reading is not always the right one.

A 0.57x result does not prove that someone will live almost twice as long, or that brain, arteries, muscle and immunity are all aging at that rate. It means something narrower: in one sample, with one algorithm, the DNA methylation pattern looked like a slower-than-reference pace of aging according to that model.

That distinction matters. At Progevita, we are interested in epigenetic clocks, but not as trophies. They are useful when they improve medical questions: what is accelerating risk, which intervention makes sense, which marker should be repeated and which number should not distract from stronger evidence.

The thesis of this article: DunedinPACE is useful when it changes better medical questions; it becomes misleading when one decimal is treated as lifespan math.

Biological age vs aging speed: odometer and speedometer

The easiest analogy is a car. Accumulated biological age is like an odometer: how much biological distance has been traveled. Aging speed is like a speedometer: how fast the system is moving now.

Early epigenetic clocks, such as Horvath and Hannum, were trained to estimate chronological age from DNA methylation. Later clocks became more risk-oriented, including PhenoAge and GrimAge. DunedinPACE changed the framing: it estimates pace of physiological aging rather than giving a biological-age number.

Measure	Question it answers	Reasonable use	Main limit
Horvath / Hannum	How old the tissue appears epigenetically.	Research and broad baseline context.	They predict chronological age better than clinical outcomes.
PhenoAge	What phenotypic-risk signal is reflected in methylation.	Mortality, healthspan and function risk.	It does not replace the clinical biomarkers behind it.
GrimAge	What epigenetic signal is linked to mortality and disease.	Risk reading, smoking exposure, inflammation and systemic burden.	Strong in cohorts, not an individual destiny score.
DunedinPACE	How fast biological aging appears to be progressing.	Trajectory and intervention follow-up.	It is a surrogate marker, not a clinical outcome.

What DunedinPACE measures

DunedinPACE came from an elegant idea: measure the rate of physiological change in people born in the same year, then translate that rate into a blood DNA-methylation signature. Belsky and colleagues used longitudinal data from the Dunedin cohort, with cardiometabolic, renal, liver, lung, immune, dental and physical markers measured over time. They then trained an algorithm to estimate that pace from methylated DNA.

The result is centered around 1.00. A value of 1.00 roughly means one biological year per calendar year. A value of 0.85 suggests a pace 15% below the reference. A value of 1.10 suggests faster pace. A 0.57 is striking because it is far from ordinary; before turning it into a headline, ask about the laboratory, sample type, repeat testing, interval, exact algorithm and whether it fits the rest of the clinical picture.

How extreme is 0.57x? In the original paper, DunedinPACE was scaled around a mean of 1.0 and an approximate standard deviation of 0.29, using a 173-CpG blood DNA-methylation signature. That helps explain why 0.57x attracts attention, but it does not turn a decimal into lifespan math. On public leaderboards such as Rejuvenation Olympics, these values are competition and tracking metrics; they are not clinical outcomes or individual life-expectancy predictions.

In the original eLife paper, DunedinPACE showed test-retest reliability and associations with morbidity, disability and mortality. In 2026, a Berlin Aging Study II analysis compared fourteen candidate aging biomarkers in adults aged 60-80 and found DunedinPACE to be the most consistent mortality predictor among those tested. That makes it interesting. It does not make it an oracle.

What a biological clock cannot promise

An epigenetic clock does not diagnose disease by itself. It does not replace an ECG, exercise test, bone-density scan, lipid profile or clinical history. It also should not be used to promise that someone has "rejuvenated X years". That phrase blends three different things: molecular change, risk change and real health outcomes.

Recent reviews are more careful than marketing. A 2025 critical review in npj Aging asked whether we actually need aging clocks in practice, because many models still carry abstract definitions, uneven clinical validation and ignored prediction uncertainty. The question is not whether clocks are useless. The question is when they add information beyond established markers.

Two technical cautions rarely appear in ads. First, many commercial reports give a point estimate without a clear individual uncertainty interval. Treating 0.72, 0.81 or 0.94 as if they were blood glucose with absolute precision is bad medicine. Second, sample type matters. A 2025 cross-tissue comparison in Aging Cell showed that blood, saliva, buccal cells, dry blood spots and PBMCs are not automatically interchangeable. Changing tissue, laboratory or pipeline can change the reading.

For now, no standard clinical screening guideline should change solely because DunedinPACE is high or low. If the number contradicts blood pressure, ApoB, glucose, inflammation, strength or symptoms, the answer is not to obey the clock: it is to review the whole case.

That is why they are surrogate markers: intermediate measures that may reflect relevant biology, but are not the same as fewer heart attacks, fewer fractures, better memory, less pain or more years of independent life.

Can aging speed change?

The honest answer is: it can move, but the size and meaning depend on context. In CALERIE, two years of calorie restriction showed a small slowing of pace measured by DunedinPACE, without clear changes in PhenoAge or GrimAge. In DO-HEALTH, omega-3, vitamin D and exercise in adults over 70 produced small DNA-methylation clock signals over three years: months, not decades.

In 2026, semaglutide data also appeared in adults with HIV-associated lipohypertrophy. The trial was randomized and double-blind, but the epigenetic analysis was post hoc, with a small cohort, 32 weeks of follow-up and a very specific population. The paper also disclosed TruDiagnostic ties: one author is a scientific advisor and two are employees. The signal is interesting, especially for inflammation, visceral fat and metabolism. It does not mean a GLP-1 drug is a general anti-aging drug for healthy people.

The same caution applies to nutrition, sauna, cold exposure, NAD+, therapeutic plasma exchange, fasting and supplements. If a clock improves but the person loses muscle, sleeps worse, gets injured or develops a worse relationship with food, the clinical balance is poor. In longevity medicine, the number matters less than the full trajectory.

How to read a 0.57x result without hype

If someone reports a biological aging speed of 0.57x, these are the useful questions:

• Which exact test was used. Commercial clocks do not all report the same thing or use the same tissue.
• Whether it was repeated. One result can capture technical noise, recent inflammation, weight loss, medication or an acute state.
• What it is being compared with. Changing laboratory or algorithm breaks the trend.
• What basic markers show. Blood pressure, HbA1c, ApoB, triglycerides, hsCRP, kidney and liver function, body composition and sleep matter a lot.
• What function shows. Strength, VO2max, balance, pain, mobility and recovery should improve alongside the number.
• Which decision changes. If no decision changes, the test may be expensive curiosity.

A mature interpretation does not chase the lowest number. It looks for coherence. A low DunedinPACE with high visceral fat, hypertension or poor aerobic capacity should not be too reassuring. A high DunedinPACE after stress, infection or sleep loss may need repetition before a whole protocol is built around it.

Which decision changes with each pattern?

Pattern	Careful reading	Reasonable next step
High once	Could be a real signal or noise from sample, lab, stress, infection or poor sleep.	Review context, fix obvious drivers and repeat with the same method if it will change decisions.
High twice and biomarkers are poor	The signal fits cardiometabolic risk, inflammation or low functional reserve.	Prioritize sleep, visceral fat, strength, VO2max, blood pressure, ApoB, glucose and inflammation.
Low, but function is poor	The clock does not cancel low strength, hypertension, poor aerobic capacity or persistent pain.	Do not use the number as permission to ignore basic clinical work.
Low and biomarkers agree	Favorable signal, useful as baseline and motivation.	Keep what is working and repeat only with a clear question.

How Progevita uses it

At Progevita, biological aging speed is interpreted inside a broader assessment, not as a medal. A serious panel combines longevity biomarkers, body composition, inflammation, cardiometabolic health, strength, cardiorespiratory fitness, sleep, clinical history and personal goals. Epigenetic clocks can add a useful layer when we know what we will do with the information.

In programs such as Optimization or Inflammaging, the practical sequence is: measure baseline, identify priorities, intervene on what is actionable, repeat what matters and adjust. If DunedinPACE is used, repeating it with the same method every 6-12 months and comparing it with real function is usually the cleanest approach. The goal is not to win a lab-score contest. It is to reduce risk, preserve autonomy and improve healthspan.

When an epigenetic clock fits the rest of the map, it can help motivate and organize decisions. When it does not fit, it should not be ignored or obeyed blindly: it should be investigated.

What to do if your pace is high

The first step is not to panic. The second is not to buy a supplement stack on impulse. A high pace should open an ordered clinical review:

• screen for insufficient sleep, sleep apnea, sustained stress or poor recovery;
• measure visceral fat, muscle mass, strength and VO2max;
• review glucose, insulin, HbA1c, ApoB, Lp(a), blood pressure and inflammation;
• look at alcohol, smoking, medication, excessive training or low energy availability;
• prioritize interventions that also improve function and risk, not only methylation.

Slower aging is not proved by a screenshot. It is proved by trend: better biomarkers, better function, lower inflammation, more strength, better sleep and better medical decisions.

Frequently asked questions about biological aging speed

What does a biological aging speed of 0.57x mean?

It means that, in that specific test, the algorithm estimated a pace below the reference average. It does not prove that the person will live almost twice as long or that every organ is aging at that speed.

Does DunedinPACE measure biological age or aging rate?

It measures pace of aging. It is closer to a speedometer than an odometer: current rate, not only accumulated biological age.

Can an epigenetic clock decide treatment?

It can add context, but it should not decide treatment alone. It should be read with blood pressure, ApoB, glucose, inflammation, body composition, strength, VO2max, sleep and clinical history.

How often should DunedinPACE be repeated?

If used for follow-up, repeating it every 6-12 months with the same laboratory usually makes more sense than testing too often.

Does a low result prove rejuvenation?

No. It can be a favorable signal, but clinical rejuvenation would require matching improvements in function, risk, symptoms and follow-up, not just one molecular score.

References

1. Horvath S. "DNA methylation age of human tissues and cell types." Genome Biology. 2013;14:R115. PMID: 24138928.
2. Levine ME, Lu AT, Quach A, et al. "An epigenetic biomarker of aging for lifespan and healthspan." Aging. 2018;10(4):573-591. PMID: 29676998.
3. Lu AT, Quach A, Wilson JG, et al. "DNA methylation GrimAge strongly predicts lifespan and healthspan." Aging. 2019;11(2):303-327. PMID: 30669119.
4. Belsky DW, Caspi A, Corcoran DL, et al. "DunedinPACE, a DNA methylation biomarker of the pace of aging." eLife. 2022;11:e73420. PMID: 35029144.
5. Waziry R, Ryan CP, Corcoran DL, et al. "Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial." Nature Aging. 2023;3:248-257. PMID: 37118425.
6. Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. "Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial." Nature Aging. 2025. PMID: 39900648.
7. Vetter VM, Drewelies J, et al. "Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II." Biomarker Research. 2026. PMID: 41792861.
8. Corley MJ, et al. "Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy." Nature Communications. 2026. PMID: 42156721.
9. Jylhävä J, Pedersen NL, Hägg S. "Biological Age Predictors." EBioMedicine. 2017;21:29-36. PMID: 28396265.
10. Kudryashova KS, Burka K, Kulaga AY, et al. "Aging Biomarkers: From Functional Tests to Multi-Omics Approaches." Proteomics. 2020;20:e1900408. PMID: 32084299.
11. Apsley AT, Caspi A, Moffitt TE, et al. "Cross-tissue comparison of epigenetic aging clocks in humans." Aging Cell. 2025. PMID: 39780748.
12. Rejuvenation Olympics. DunedinPACE leaderboard.
13. TruDiagnostic. DunedinPACE overview.
14. Moody Longevity Trial. "Tirzepatide to Slow Biological Aging." ClinicalTrials.gov: NCT07220473.
15. Nelson et al. "Do we actually need aging clocks?" npj Aging. 2025. DOI: 10.1038/s41514-025-00312-2.

This article is informational and does not replace individual medical assessment. Epigenetic clocks should be interpreted alongside clinical history, biomarkers, physical function and real goals.

Want to measure biological aging speed with medical context, not as an isolated number? Request an integrated Progevita assessment.